ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,477Medicare Part D Prescriptions Filled, Including Refills

Rank: 126 out of 973

$551K Total Retail Price of All Prescriptions

Rank: 104 out of 973

398 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 398 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,693 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
FUROSEMIDE 488 411 1 6
HYDROCODONE-ACETAMINOPHEN 417 285 S3 2 4
POTASSIUM CHLORIDE 373 325 3 9
SIMVASTATIN 311 261 4 1
OMEPRAZOLE 255 202 5 5
LISINOPRIL 221 191 6 3
LEVOTHYROXINE SODIUM 211 184 7 2
MELOXICAM 207 195 8 23
GABAPENTIN 188 156 9 12
AMLODIPINE BESYLATE 188 166 9 7
CITALOPRAM HBR 182 140 11 14
ENALAPRIL MALEATE 181 156 12 55
HYDROCHLOROTHIAZIDE 155 143 13 11
METFORMIN HCL 142 113 14 8
DOXAZOSIN MESYLATE 128 122 15 87
DILTIAZEM 24HR CD 127 123 16 104
POLYETHYLENE GLYCOL 3350 126 116 17 36
METOPROLOL TARTRATE 124 109 18 13
LOSARTAN POTASSIUM 119 119 19 19
CYMBALTA 116 67 20 40
LANTUS 109 94 21 39
GLIMEPIRIDE 106 73 22 41
TRAZODONE HCL 103 74 23 48
TRAMADOL HCL 100 72 24 18
ATORVASTATIN CALCIUM 99 82 25 15
DIGOXIN 97 86 26 32
RANITIDINE HCL 95 90 27 45
AZITHROMYCIN 90 77 28 47
WARFARIN SODIUM 88 87 29 10
METFORMIN HCL ER 86 61 30 58
NOVOLOG 84 66 31 82
DIVALPROEX SODIUM 84 67 31 86
MUPIROCIN 84 52 31 151
ATENOLOL 83 62 34 16
CARBIDOPA-LEVODOPA 82 76 35 71
CEPHALEXIN 74 64 36 75
CLONIDINE HCL 73 67 37 67
JANTOVEN 72 71 38 113
ALENDRONATE SODIUM 72 71 38 24
METOCLOPRAMIDE HCL 70 60 40 93
FLUTICASONE PROPIONATE 65 64 41 35
MIRTAZAPINE 64 63 42 43
BENAZEPRIL HCL 62 59 43 62
KLOR-CON 10 61 39 44 128
DIOVAN 61 48 44 63
DONEPEZIL HCL 60 60 46 26
SERTRALINE HCL 59 58 47 21
CIPROFLOXACIN HCL 59 41 47 57
NYSTATIN 59 51 47 149
JANUVIA 58 32 50 88
METOPROLOL SUCCINATE 56 56 51 17
OXYBUTYNIN CHLORIDE ER 54 42 52 125
TAMSULOSIN HCL 54 48 52 28
CLOPIDOGREL 54 54 52 44
PLAVIX 54 52 52 78
TRIAMTERENE-HCTZ 53 53 56 51
ZETIA 52 52 57 81
ALLOPURINOL 51 24 58 29
FAMOTIDINE 51 44 58 61
PREDNISONE 50 40 60 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.